Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
DEA implements the SUPPORT Act, expanding medication-assisted treatment (MAT) via new rules for dispensing and administering controlled substances, including telemedicine flexibilities and updated registration requirements.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 30, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense or administer controlled substances for MAT. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Effective 30 days after publication in the Federal Register (publication date June 9, 2026; effective date July 9, 2026).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New DEA regulations under the SUPPORT Act modify requirements for prescribing, dispensing, and administering controlled substances (e.g., buprenorphine) for MAT, including telemedicine allowances, patient limits, and recordkeeping.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense or administer controlled substances for MAT.
What you must do
Review the final rule to update MAT dispensing protocols, ensure compliance with new telemedicine prescribing rules, and adjust patient limit tracking if applicable.
Deadline
Effective 30 days after publication in the Federal Register (publication date June 9, 2026; effective date July 9, 2026).
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- New Maine law increases access to birth control at pharmacies - WGME
- Andrew Jonathan Morgan: Final Debarment Order
- SpecGx LLC; Withdrawal of Approval of Abbreviated New Drug Application for Methylphenidate Hydrochloride Extended-Release Tablets, 27 Milligrams, 36 Milligrams, and 54 Milligrams
- Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
- Schedules of Controlled Substances: Rescheduling of Marijuana; Withdrawal